Постковидный синдром в практике терапевта
- Авторы: Скворцов В.В1, Тумаренко А.В1, Скворцова Е.М1, Штонда Д.А1
-
Учреждения:
- Волгоградский государственный медицинский университет Минздрава России
- Выпуск: Том 33, № 4 (2022)
- Страницы: 19-28
- Раздел: Статьи
- URL: https://journals.eco-vector.com/0236-3054/article/view/114591
- DOI: https://doi.org/10.29296/25877305-2022-04-03
- ID: 114591
Цитировать
Полный текст
![Открытый доступ](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_open.png)
![Доступ закрыт](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_unlock.png)
![Доступ закрыт](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Аннотация
Постковидный синдром (ПКС) (post-COVID-19 syndrome, Long COVID, postacute sequelae of COVID-19, PASC, chronic COVID syndrome, CCS, long-haul COVID) является последствием новой коронавирусной инфекции (COVID-19), при которой до 20% людей, перенесших коронавирусную инфекцию, страдают от долгосрочных симптомов (>12 нед). ПКС представлен в МКБ-10 кодом U09.9 «Состояние после COVID-19 неуточненное». Универсальный консенсус в определении ПКС отсутствует. Некоторые авторы предполагают, что подострый период начинается через 3 нед после появления симптомов, поскольку средняя продолжительность положительного результата полимеразной цепной реакции у пациентов с симптомами оценивается в 24 дня.
Ключевые слова
Полный текст
![Доступ закрыт](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Об авторах
В. В Скворцов
Волгоградский государственный медицинский университет Минздрава России
Email: vskvortsov1@ya.ru
доктор медицинских наук, профессор
А. В Тумаренко
Волгоградский государственный медицинский университет Минздрава России
Email: vskvortsov1@ya.ru
кандидат медицинских наук, доцент
Е. М Скворцова
Волгоградский государственный медицинский университет Минздрава России
Email: vskvortsov1@ya.ru
Д. А Штонда
Волгоградский государственный медицинский университет Минздрава России
Автор, ответственный за переписку.
Email: vskvortsov1@ya.ru
Список литературы
- Escher F., Pietsch H., Aleshcheva G. et al. Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies. ESC Heart Fail. 2020; 7 (5): 2440-7. doi: 10.1002/ehf2.12805
- Chopra V., Flanders S.A., O'Malley M. et al. Sixty-Day Outcomes Among Patients Hospitalized With COVID-19. Ann Intern Med. 2021; 174 (4): 576-8. doi: 10.7326/M20-5661
- Arnold D.T., Hamilton F.W., Milne A. et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2021; 76 (4): 399-401. doi: 10.1136/thoraxjnl-2020-216086
- Wu Q., Zhou L., Sun X. et al. Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection. Sci Rep. 2017; 7 (1): 9110. doi: 10.1038/s41598-017-09536-z
- Chaudhary R., Kreutz R.P., Bliden K.P. et al. Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry. Thromb Haemost. 2020; 120 (11): 1594-6. doi: 10.1055/s-0040-1714217
- Oronsky B., Larson C., Hammond T.C. et al. A review of persistent post-COVID syndrome (PPCS). Clin Rev Allergy Immunol. 2021; 1-9. [Epub ahead of print]. DOI: 10.1007/ s12016-021-08848-3
- Salmon-Ceron D., Slama D., De Broucker T. et al. APHP COVID-19 research collaboration. Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: a cross-sectional study. J Infect. 2021; 82: e1-4. doi: 10.1016/j.jinf.2020.12.002
- Carmo A., Pereira-Vaz J., Mota V. et al. Clearance and persistence of SARS-CoV-2 RNA in patients with COVID. J Med Virol. 2020; 92 (10): 2227-31. doi: 10.1002/jmv.26103
- Kandetu T.B., Dziuban E.J., Sikuvi K. et al. Persistence of positive RT-PCR results for over 70 days in two travelers with COVID-19. Disaster Med Public Health Prep. 2020; 1-2. doi: 10.1017/dmp.2020.450
- Vibholm L.K., Nielsen S.S.F., Pahus M.H. et al. SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses. EBioMedicine. 2021; 64: 103230. DOI: 10.1016/j. ebiom.2021.103230
- Wang X., Huang K., Jiang H. et al. Long-term existence of SARS-CoV-2 in COVID-19 patients: host immunity, viral virulence, and transmissibility. Virol Sin. 2020; 35 (6): 793-802. doi: 10.1007/s12250-020-00308-0
- Кудлай Д.А., Широбоков Я.Е., Гладунова Е.П. и др. Диагностика COVID-19. Способы и проблемы обнаружения вируса SARS-COV-2 в условиях пандемии. Врач. 2020; 31 (8): 5-10. doi: 10.29296/25877305-2020-08-01
- Hirotsu Y., Maejima M., Shibusawa M. et al. Analysis of a persistent viral shedding patient infected with SARS-CoV-2 by RT-qPCR, FilmArray Respiratory Panel v2.1, and antigen detection. J Infect Chemother. 2020; 27 (2): 406-9. doi: 10.1016/j.jiac.2020.10.026
- Li Q., Zheng X.S., Shen X.R. et al. Prolonged shedding of severe acute respiratory syndrome coronavirus 2 in patients with COVID-19. Emerg Microbes Infect. 2020; 9 (1): 2571-7. doi: 10.1080/22221751.2020.1852058
- Park S.K., Lee C., Park D. et al. Detection of SARS-CoV-2 in fecal samples from patients with asymptomatic and mild COVID-19 in Korea. Clin Gastroenterol Hepatol. 2020; 19 (7): 1387-94.e2. doi: 10.1016/j.cgh.2020.06.005
- Wu Y., Guo C., Tang L. et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. 2020; 5 (5): 434-5. doi: 10.1016/S2468-1253(20)30083-2
- Gaebler C., Wang Z., Lorenz J.C.C. et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021; 591 (7851): 639-44. doi: 10.1038/s41586-021-03207-w
- Ehrenfeld M., Tincani A., Andreoli L. et al. COVID-19 and autoimmunity. Autoimmun Rev. 2020; 19 (8): 102597. doi: 10.1016/j.autrev.2020.102597
- Lui D.T.W., Lee C.H., Chow W.S. et al. Thyroid dysfunction in relation to immune profile, disease status and outcome in 191 patients with COVID-19. J Clin Endocrinol Metab. 2020; 106 (2): e926-e935. doi: 10.1210/clinem/dgaa813
- Muller I., Cannavaro D., Dazzi D. et al. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. 2020; 8 (9): 739-41. doi: 10.1016/S2213-8587(20)30266-7
- Li Q., Wang B., Mu K. et al. The pathogenesis of thyroid autoimmune diseases: New T lymphocytes - Cytokines circuits beyond the Th1-Th2 paradigm. J Cell Physiol. 2019; 234 (3): 2204-16. doi: 10.1002/jcp.27180
- Zuo Y., Estes S.K., Ali R.A. et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med. 2020; 12: eabd3876. doi: 10.1126/scitranslmed. abd3876
- Bastard P., Rosen L.B., Zhang Q. et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020; 370 (6515): 370. doi: 10.1126/science. abd4585
- Gao Z.W., Zhang H., Liu C. et al. Autoantibodies in COVID-19: frequency and function. Autoimmun Rev. 2021; 20 (3): 102754. doi: 10.1016/j.autrev.2021.102754
- Vlachoyiannopoulos P.G., Magira E., Alexopoulos H. et al. Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19. Ann Rheum Dis. 2020; 79 (12): 1661-3. doi: 10.1136/annrheumdis-2020-218009
- Zhou Y., Han T., Chen J. et al. Clinical and autoimmune characteristics of severe and critical cases of COVID. Clin Transl Sci. 2020; 13 (6): 1077-86. doi: 10.1111/cts.12805
- Elkon K., Casali P. Nature and functions of autoantibodies. Nat Clin Pract Rheumatol. 2008; 4 (9): 491-8. doi: 10.1038/ncprheum0895
- Cojocaru M., Cojocaru I.M., Silosi I. et al. Manifestations of systemic lupus erythematosus. Maedica (Bucur). 2011; 6 (4): 330-6.
- Guo Q., Wang Y., Xu D. et al. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018; 6: 15. doi: 10.1038/s41413-018-0016-9
- Fathi N., Rezaei N. Lymphopenia in COVID-19: therapeutic opportunities. Cell Biol Int. 2020; 44 (9): 1792-7. doi: 10.1002/cbin.11403
- Tavakolpour S., Rakhshandehroo T., Wei E.X. et al. Lymphopenia during the COVID-19 infection: What it shows and what can be learned. Immunol Lett. 2020; 225: 31-2. doi: 10.1016/j.imlet.2020.06.013
- Cheng Y., Zhao H., Song P. et al. Dynamic changes of lymphocyte counts in adult patients with severe pandemic H1N1 influenza A. J Infect Public Health. 2019; 12 (6): 878-83. doi: 10.1016/j.jiph.2019.05.017
- Kong M., Zhang H., Cao X. et al. Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19. Epidemiol Infect. 2020; 148: e139. doi: 10.1017/S0950268820001557
- Danwang C., Endomba F.T., Nkeck J.R. et al. A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19). Biomark Res. 2020; 8 (1): 37. doi: 10.1186/s40364-020-00217-0
- Malik P., Patel U., Mehta D. et al. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ Evid Based Med. 2020; 26 (3): 107-8. doi: 10.1136/bmjebm-2020-111536
- Ou M., Zhu J., Ji P. et al. Risk factors of severe cases with COVID-19: a meta-analysis. Epidemiol Infect. 2020; 148: e175. doi: 10.1017/S095026882000179X
- Hu F., Chen F., Ou Z. et al. A compromised specific humoral immune response against the SARS-CoV-2 receptor-binding domain is related to viral persistence and periodic shedding in the gastrointestinal tract. Cell Mol Immunol. 2020; 17 (11): 1119-25. doi: 10.1038/s41423-020-00550-2
- Lamers M.M., Beumer J., Vaart J. et al. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020; 369 (6499): 50-4. doi: 10.1126/science.abc1669
- Xiao F., Tang M., Zheng X. et al. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020; 158 (6): 1831-1833.e3. doi: 10.1053/j.gastro.2020.02.055
- Zang R., Castro M.F.G., McCune B.T. et al. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci Immunol. 2020; 5 (47): eabc3582. doi: 10.1126/sciimmunol.abc3582
- Cheung K.S., Hung I.F.N., Chan P.P.Y. et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong Cohort: systematic review and meta-analysis. Gastroenterology. 2020; 159 (1): 81-95. doi: 10.1053/j.gastro.2020.03.065
- Mao R., Qiu Y., He J.S. et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020; 5 (7): 667-8. doi: 10.1016/S2468-1253(20)30126-6
- Liang L., Yang B., Jiang N. et al. Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge. J Korean Med Sci. 2020; 35 (47): e418. doi: 10.3346/jkms.2020.35.e418
- Petersen M.S., Kristiansen M.F., Hanusson K.D. et al. Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients. Clin Infect Dis. 2021; 73 (11): e4058-e4063. doi: 10.1093/cid/ciaa1792
- Zhao Y.M., Shang Y.M., Song W.B. et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020; 25: 100463. doi: 10.1016/j.eclinm.2020.100463
- Yeoh Y.K., Zuo T., Lui G.C.-Y. et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021; 70 (4): 698-706. doi: 10.1136/gutjnl-2020-323020
- Zuo T., Zhan H., Zhang F. et al. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge. Gastroenterology. 2020; 159 (4): 1302-1310.e5. doi: 10.1053/j.gastro.2020.06.048
- Zuo T., Zhang F., Lui G.C.Y. et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020; 159 (3): 944-955.e8. DOI: 10.1053/j. gastro.2020.05.048
- Belkaid Y., Hand T.W. Role of the microbiota in immunity and inflammation. Cell. 2014; 157 (1): 121-50. doi: 10.1016/j.cell.2014.03.011
- Yong S.J., Tong T., Chew J. et al. Antidepressive mechanisms of probiotics and their therapeutic potential. Front Neurosci. 2019; 13: 1361. doi: 10.3389/fnins.2019.01361
- Williamson E.J., Walker A.J., Bhaskaran K. et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020; 584 (7821): 430-6. doi: 10.1038/s41586-020-2521-4
- Huang C., Huang L., Wang Y. et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021; 397 (10270): 220-32. DOI: 10.1016/ S0140-6736(20)32656-8
- Бородулина Е.А., Широбоков Я.Е., Гладунова Е.П. и др. Диагностика и фармакотерапия вирус-ассоциированных поражений легких. Клиническая фармакология и терапия. 2020; 29 (3): 61-6. doi: 10.32756/0869-5490-2020-3-61-66
- Burnham E.L., Janssen W.J., Riches D.W. et alP. The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance. Eur Respir J. 2014; 43 (1): 276-85. doi: 10.1183/09031936.00196412
- Ackermann M., Verleden S.E., Kuehnel M. et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19. N Engl J Med. 2020; 383 (2): 120-8. doi: 10.1056/NEJMoa2015432
- Chippa V., Aleem A., Anjum F. Post Acute Coronavirus (COVID-19) Syndrome. [Updated 2021 Oct 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2021.
- Lindner D., Fitzek A., Brauninger H. et al. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. JAMA Cardiol. 2020; 5 (11): 1281-5. doi: 10.1001/jamacardio.2020.3551
- Solomon I.H., Normandin E., Bhattacharyya S. et al. Neuropathological Features of COVID-19. N Engl J Med. 2020; 383 (10): 989-92. doi: 10.1056/NEJMc2019373
- Peleg Y., Kudose S., D'Agati V. et al. Acute Kidney Injury Due to Collapsing Glomerulopathy Following COVID-19 Infection. Kidney Int Rep. 2020; 5 (6): 940-5. doi: 10.1016/j.ekir.2020.04.017
- Kaseda E.T., Levine A.J. Post-traumatic stress disorder: A differential diagnostic consideration for COVID-19 survivors. Clin Neuropsychol. 2020; 34 (7-8): 1498-514. doi: 10.1080/13854046.2020.1811894
- Mo X., Jian W., Su Z. et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020; 55: 2001217. doi: 10.1183/13993003.01217-2020
- Shah A.S., Wong A.W., Hague C.J. et al. A prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations. Thorax. 2021; 76: 402-4. DOI: 10.1136/ thoraxjnl-2020-216308
- Carvalho-Schneider C., Laurent E., Lemaignen A. et al. Follow-up of adults with non-critical COVID-19 two months after symptoms' onset. Clin Microbiol Infect. 2021; 27: 258-63. doi: 10.1016/j.cmi.2020.09.052
- Carfi A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID19. JAMA. 2020; 324: 603-5. doi: 10.1001/jama.2020.12603
- Nalbandian A., Sehgal K., Gupta A. et al. Post-acute COVID-19 syndrome. Nat Med. 2021; 27: 601-15. doi: 10.1038/s41591-021-01283-z
- Puntmann V.O., Carerj M.L., Wieters I. et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020; 5: 1265-73. doi: 10.1001/jamacardio.2020.3557
- Patell R., Bogue T., Koshy A. et al. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood. 2020; 136: 1342-6. doi: 10.1182/blood.2020007938
- Taquet M., Geddes J.R., Husain M. et al. 6-month neurological and psychiatric outcomes in 236379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021; 8 (5): 416-27. doi: 10.1016/S2215-0366(21)00084-5
- Sampaio Rocha-Filho P.A., Voss L. Persistent headache and persistent anosmia associated with COVID-19. Headache. 2020; 60: 1797-9. doi: 10.1111/head.13941
- Liu J.W.T.W., de Luca R.D., Mello Neto H.O. et al. Post- COVID-19 syndrome? New daily persistent headache in the aftermath of COVID-19. Arq Neuropsiquiatr. 2020; 78 (11): 753-4. doi: 10.1590/0004-282X20200187
- Dani M., Dirksen A., Taraborrelli P. et al. Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Clin Med (Lond). 2021; 21 (1): e63-7. doi: 10.7861/clinmed.2020-0896
- Дедов Д.В. Новая коронавирусная инфекция: клинико-патогенетические аспекты, профилактика, значение витаминов и микроэлементов. Врач. 2022; 33 (2): 47-9. doi: 10.29296/25877305-2022-02-07
- Дедов Д.В., Марченко С.Д. Витамины, железо, цинк, селен, селенсодержащие лекарственные препараты в комплексной профилактике осложнений и лечении больных COVID-19. Фармация. 2022; 71 (1): 5-9. doi: 10.29296/25419218-2022-01-01
Дополнительные файлы
![](/img/style/loading.gif)